通过PDK4介导的Nrf2无活化有助于氧化应激和糖尿病损伤

Shasha Tian1, Xiaopeng Yang1, Yao Lin1

  • 1NHC Key Laboratory of Hormones and Development, Chu Hsien-I Memorial Hospital and Tianjin Institute of Endocrinology, Tianjin Medical University, Tianjin 300134, China; Tianjin Key Laboratory of Metabolic Diseases, Tianjin Medical University, Tianjin 300134, China.

Cellular signalling
|July 6, 2024
PubMed
概括

酸盐脱酶激酶4 (PDK4) 通过破坏氧化还原平衡驱动糖尿病病 (DKD). 抑制PDK4可以恢复主抗氧化剂Nrf2,为DKD提供潜在的治疗策略.